Hepatitis Monthly

Published by: Kowsar

Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers

Mohammad Saeid Rezaee-Zavareh 1 , 2 , Hamidreza Karimi-Sari 1 , 2 , Fardin Dolatimehr 1 , 2 and Seyed Moayed Alavian 2 , *
Authors Information
1 Students Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Middle East Liver Diseases Center (MELD), Tehran, IR Iran
Article information
  • Hepatitis Monthly: December 01, 2015, 15 (12); e35238
  • Published Online: December 29, 2015
  • Article Type: Review Article
  • Received: December 4, 2015
  • Accepted: December 4, 2015
  • DOI: 10.5812/hepatmon.35238

To Cite: Rezaee-Zavareh M S, Karimi-Sari H, Dolatimehr F, Alavian S M. Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers, Hepat Mon. 2015 ;15(12):e35238. doi: 10.5812/hepatmon.35238.

Abstract
Copyright © 2015, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
References
  • 1. Lankarani KB, Mahmoodi M, Honarvar B, Nematollahi P, Zamiri N, Ghaffarpasand F. Determinants of poor outcome in patients with hepatitis A infection: a four-year retrospective study in Shiraz, Southern Iran. Arch Virol. 2014; 159(8): 1901-7[DOI][PubMed]
  • 2. Jamali R. Epidemiologic Studies on Viral Hepatitis: A Short Review. Thrita. 2014; 3(1)
  • 3. Almuneef MA, Memish ZA, Balkhy HH, Otaibi B, Helmi M. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Infect Control Hosp Epidemiol. 2006; 27(11): 1178-83[DOI][PubMed]
  • 4. Grzeszczuk A, Sokolewicz-Bobrowska E, Chlabicz S. Occupational risk of hepatitis A infection among health care providers in northeastern Poland. Med Sci Monit. 2003; 9(7)-4[PubMed]
  • 5. Jung SI, Lee CS, Park KH, Kim ES, Kim YJ, Kim GS, et al. Sero-epidemiology of hepatitis A virus infection among healthcare workers in Korean hospitals. J Hosp Infect. 2009; 72(3): 251-7[DOI][PubMed]
  • 6. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011; 11(4): 285-8[PubMed]
  • 7. Lemon SM, Jansen RW, Brown EA. Genetic, antigenic and biological differences between strains of hepatitis A virus. Vaccine. 1992; 10 Suppl 1-4[PubMed]
  • 8. Alavi Moghaddam M. Hepatitis A virus: a major global public health problem, especially in developing countries. Hepat Mon. 2005; 5(4): 145-9
  • 9. Melhem NM, Talhouk R, Rachidi H, Ramia S. Hepatitis A virus in the Middle East and North Africa region: a new challenge. J Viral Hepat. 2014; 21(9): 605-15[DOI][PubMed]
  • 10. Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, Azimzadeh P, et al. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg. 2012; 106(9): 528-31[DOI][PubMed]
  • 11. Jeong SH, Lee HS. Hepatitis A: clinical manifestations and management. Intervirology. 2010; 53(1): 15-9[DOI][PubMed]
  • 12. Fiore AE. Hepatitis A transmitted by food. Clin Infect Dis. 2004; 38(5): 705-15[DOI][PubMed]
  • 13. Arguedas MR, Fallon MB. Hepatitis A. Curr Treat Options Gastroenterol. 2004; 7(6): 443-50[DOI]
  • 14. Yeung LT, Roberts EA. Current issues in the management of paediatric viral hepatitis. Liver Int. 2010; 30(1): 5-18[DOI][PubMed]
  • 15. Brundage SC, Fitzpatrick AN. Hepatitis A. Am Fam Physician. 2006; 73(12): 2162-8[PubMed]
  • 16. Ghorbani GA, Mahboobi N, Lankarani KB, Alavian SM. Hepatitis A Prevention Strategies, Haiti Case: Should Rescuers Be Immunized. Iran Red Crescent Med J. 2010; 2010(3): 221-3
  • 17. Matheny SC, Kingery JE. Hepatitis A. Am Fam Physician. 2012; 86(11): 1027-34[PubMed]
  • 18. Guturu P, Cicalese L, Duchini A. Hepatitis A vaccination in healthcare personnel. Ann Hepatol. 2012; 11(3): 326-9[PubMed]
  • 19. Das A. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Hepatology. 1999; 29(2): 548-52[DOI][PubMed]
  • 20. Mahboobi N, Safari S, Alavian SM. Hepatitis A virus in Middle East countries: More evidence needed. Arab J Gastroenterol. 2010; 11(1): 1-2[DOI]
  • 21. Mahboobi N, Alavian SM. Hepatitis A in the Eastern Mediterranean region: a review on the prevalence. Scimetr. 2013; 2(1)
  • 22. Khedmat H, Taheri S. Immunization of rescuers against hepatitis A virus infection in disasterous areas. Iran Red Crescent Med J. 2010; 2010(6): 673-4
  • 23. Elizee PK, Alavian SM. Prevention of hepatitis a virus infection, need to vaccinate or not? Int J Prev Med. 2013; 4(8): 863-5[PubMed]
  • 24. Ghorbani GA. Is evaluation of hepatitis a immunity required or not? Hepat Mon. 2011; 11(12): 955-7[DOI][PubMed]
  • 25. Jacobs RJ, Gibson GA, Meyerhoff AS. Cost-effectiveness of hepatitis A-B vaccine versus hepatitis B vaccine for healthcare and public safety workers in the western United States. Infect Control Hosp Epidemiol. 2004; 25(7): 563-9[DOI][PubMed]
  • 26. Rajan E, Shattock AG, Fielding JF. Cost-effective analysis of hepatitis A prevention in Ireland. Am J Gastroenterol. 2000; 95(1): 223-6[DOI][PubMed]
  • 27. Bayani M, Sadeghi M, Kalantari N, Sayadmanesh A. Hepatitis a virus seropositivity in nurses and paramedical personnel at a university hospital in north iran. Iran Red Crescent Med J. 2013; 15(5): 409-13[DOI][PubMed]
  • 28. Saeidi AA, Darvishi M, Faraji S, Soleiman MS, Aminianfar M. Sero-prevalence of antibody to hepatitis a in adults personnel of a military hospital in tehran. J Nurse Phys War. 2014; 2(2): 35-7
  • 29. Safaar MJ, Jooyan AR, Mahdavi MR, Khalilian AR. Seroprevalence of hepatitis a, b, and c and hepatitis b vaccination status among health care workers in sari–iran 2003. J Mazandaran Univ Med Sci. 2005; 15(47): 67-77
  • 30. Hosseini Shokouh SJ, Dadashi A, Abiri M, Zohrevand I, Eshraghian A, Khoshdel A, et al. HAV Immunity in Iranian Medical Students. Hepat Mon. 2015; 15(3)[DOI][PubMed]
  • 31. Bayani M, Hasanjani Roushan MR, Javanian M, Kalantari N, Hajitabar M. Hepatitis A antibody seroprevalence among students of Babol university of medical sciences; Babol, Iran. J Babol Univ Med Sci. 2014; 16(3): 49-53
  • 32. Vakili B, Rahimi H, Ataei B, Janghorbani M, Khorvash F, Shoaei P, et al. Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: A seroprevalence study. J Res Med Sci. 2014; 19
  • 33. Arankalle VA, Chadha MS. Who should receive hepatitis A vaccine? J Viral Hepat. 2003; 10(3): 157-8[DOI]
  • 34. Karimi Elizee P, Alavian SM, Miri SM, Behnava B, Alavian SH, Keshvari M, et al. The seroprevalence of entrically transmitted viral hepatitis in hcv infected thalassemia and hemophilia patients in iran. Jundishapur J Microbiol. 2013; 6(7)
  • 35. Alavian SM. Vaccination in Health Care Workers Should be Following in our Country Now?! Iran Red Crescent Med J. 2013; 15(12)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments